Attached files
| file | filename |
|---|---|
| EX-31.1 - AIM ImmunoTech Inc. | v211077_ex31-1.htm |
| EX-32.2 - AIM ImmunoTech Inc. | v211077_ex32-2.htm |
| EX-32.1 - AIM ImmunoTech Inc. | v211077_ex32-1.htm |
| EX-31.2 - AIM ImmunoTech Inc. | v211077_ex31-2.htm |
| EX-10.26 - AIM ImmunoTech Inc. | v211077_ex10-26.htm |
| 10-K/A - AIM ImmunoTech Inc. | v211077_10ka.htm |
Exhibit
23.1
Consent
of Independent Registered Public Accounting Firm
Hemispherx
Biopharma, Inc.
Philadelphia,
Pennsylvania
We
consent to the incorporation by reference in the Registration Statements (No.s
333-160499, 333-57134, 118903 and 333-155528) on Form S-8 and the Registration
Statements (No.s 333-136187, 333-117178, 333-119017, 333-108645,
333-111135, 333-113796, 333-130008, 333-159856 and 333-151696) on Form S-3 of
Hemispherx Biopharma, Inc. and Subsidiaries of our reports dated March 12, 2010,
except for Notes 17 and 18, as to which the date is February 11, 2011,
relating to our audit of the consolidated financial statements and the financial
statement schedule, and internal control over financial reporting, which appear
in this Annual Report on Form 10-K/A-2 of Hemispherx Biopharma, Inc. for the
year ended December 31, 2009.
|
/s/ McGladrey & Pullen
LLP
|
|
McGladrey
& Pullen LLP
|
Blue
Bell, Pennsylvania
February
11, 2011